Label: SENNA- sennosides tablet
- NDC Code(s): 68016-832-01
- Packager: PHARMACY VALUE ALLIANCE LLC
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated December 6, 2023
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Active ingredient (in each tablet)
- Purpose
- Uses
-
Warnings
Do not use
for more than one week unless directed by a doctor.
Ask a doctor before use if you
• have stomach pain, nausea or vomiting
• have noticed a sudden change in bowel habits that lasts over 2 weeks
Stop use and ask a doctor ifyou have rectal bleeding or fail to have a bowel movement after use of a laxative.
These may indicate a serious condition.
If pregnant or breast-feeding, ask a health professional before use. - Directions
- Other information
- Inactive ingredients
- Package Label
-
INGREDIENTS AND APPEARANCE
SENNA
sennosides tabletProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:68016-832 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX) SENNOSIDES 8.6 mg Inactive Ingredients Ingredient Name Strength CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) CROSCARMELLOSE SODIUM (UNII: M28OL1HH48) DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) MAGNESIUM STEARATE (UNII: 70097M6I30) TALC (UNII: 7SEV7J4R1U) TRIACETIN (UNII: XHX3C3X673) HYPROMELLOSES (UNII: 3NXW29V3WO) Product Characteristics Color brown Score no score Shape ROUND Size 9mm Flavor Imprint Code PS23 Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:68016-832-01 100 in 1 BOTTLE; Type 0: Not a Combination Product 12/01/2022 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug 505G(a)(3) 12/01/2022 Labeler - PHARMACY VALUE ALLIANCE LLC (101668460) Registrant - Geri-Care Pharmaceutical Corp (611196254)